Zeskind Benjamin J.

CIK 00018700621 companyCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001870062

Recent Transactions

25 trades

Purchase
Immuneering Corp$IMRX
Class A Common Stock
2025-07-02$3.53/sh+7,015→ 2,312,852 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2025-07-01$3.38/sh+2,985→ 2,305,837 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2025-06-18$2.39/sh+21,000→ 2,302,852 total
Award
Immuneering Corp$IMRX
Stock Option
2025-02-05+480,000→ 480,000 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2024-03-19$2.77/sh+20,000→ 2,281,852 total
Award
Immuneering Corp$IMRX
Stock Option
2024-02-08+244,286→ 244,286 total
Award
Immuneering Corp$IMRX
Stock Option
2024-02-08+16,414→ 16,414 total
Award
Immuneering Corp$IMRX
Stock Option
2023-02-15+21,756→ 374,000 total
Award
Immuneering Corp$IMRX
Stock Option
2023-02-15+352,244→ 352,244 total
Exercise/Conversion
Immuneering Corp$IMRX
Class A Common Stock
2022-12-22$3.01/sh+2,500→ 2,261,852 total
Exercise/Conversion
Immuneering Corp$IMRX
Stock Option
2022-12-22−2,500→ 203,500 total
Exercise/Conversion
Immuneering Corp$IMRX
Stock Option
2022-04-12−2,000→ 206,000 total
Exercise/Conversion
Immuneering Corp$IMRX
Class A Common Stock
2022-04-12$3.01/sh+2,000→ 2,259,352 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2022-03-23$8.02/sh+3,000→ 2,257,352 total
Exercise/Conversion
Immuneering Corp$IMRX
Stock Option
2022-02-28−2,000→ 208,000 total
Exercise/Conversion
Immuneering Corp$IMRX
Class A Common Stock
2022-02-28$3.01/sh+2,000→ 2,254,352 total
Award
Immuneering Corp$IMRX
Stock Option
2022-02-10+45,615→ 202,100 total
Award
Immuneering Corp$IMRX
Stock Option
2022-02-10+156,485→ 156,485 total
Gift
Immuneering Corp$IMRX
Class A Common Stock
2021-10-22−350,000→ 2,252,352 total
Gift
Immuneering Corp$IMRX
Class A Common Stock
2021-10-22+350,000→ 894,927 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2021-09-13$22.87/sh+2,083→ 2,602,352 total
Purchase
Immuneering Corp$IMRX
Class A Common Stock
2021-08-03$15.00/sh+2,098→ 2,600,269 total
Conversion
Immuneering Corp$IMRX
Series B Preferred Stock
2021-08-03−8,171→ 0 total
Conversion
Immuneering Corp$IMRX
Class A Common Stock
2021-08-03+49,099→ 2,598,171 total
Conversion
Immuneering Corp$IMRX
Series A Preferred Stock
2021-08-03−40,928→ 0 total

Companies

Immuneering Corp
Director, PRESIDENT AND CEO, 10% Owner
$IMRX

Recent Filings

Address

245 MAIN STREET SECOND FLOOR

CAMBRIDGE, MA, 02142

View on SEC.gov